Tenax Therapeutics Inc (NASDAQ: TENX) kicked off on November 20, 2023, at the price of $0.36, down -5.22% from the previous trading day. During the day, the shares moved up to $0.3779 and dropped to $0.32 before settling in for the closing price of $0.38. Over the past 52 weeks, TENX has traded in a range of $0.15-$4.30.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
While this was happening, its average annual earnings per share was recorded 95.65%. With a float of $23.27 million, this company’s outstanding shares have now reached $23.86 million.
Let’s look at the performance matrix of the company that is accounted for 7 employees.
Tenax Therapeutics Inc (TENX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tenax Therapeutics Inc is 2.49%, while institutional ownership is 2.46%.
Tenax Therapeutics Inc (TENX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 6/29/2023, the organization reported -$0.05 earnings per share (EPS), higher than consensus estimate (set at -$0.1) by $0.05. This company achieved a return on equity of -385.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 95.65% per share during the next fiscal year.
Tenax Therapeutics Inc (NASDAQ: TENX) Trading Performance Indicators
Take a look at Tenax Therapeutics Inc’s (TENX) current performance indicators. Last quarter, stock had a quick ratio of 19.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.40, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of Tenax Therapeutics Inc (TENX)
Tenax Therapeutics Inc (NASDAQ: TENX) saw its 5-day average volume 20.59 million, a positive change from its year-to-date volume of 3.47 million. As of the previous 9 days, the stock’s Stochastic %D was 38.53%. Additionally, its Average True Range was 0.08.
During the past 100 days, Tenax Therapeutics Inc’s (TENX) raw stochastic average was set at 34.27%, which indicates a significant increase from 34.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 594.44% in the past 14 days, which was higher than the 240.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2906, while its 200-day Moving Average is $0.3987. Nevertheless, the first resistance level for the watch stands at $0.3862 in the near term. At $0.4110, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4441. If the price goes on to break the first support level at $0.3283, it is likely to go to the next support level at $0.2952. The third support level lies at $0.2704 if the price breaches the second support level.
Tenax Therapeutics Inc (NASDAQ: TENX) Key Stats
The company with the Market Capitalisation of 8.62 million has total of 23,862K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -11,050 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -1,110 K.